Sidebar

Vilmante Zitkute  

Email:

ORCID
LinkedIn
ResearchGate

CV for Download

Research Interests: Molecular mechanisms of cell death and survival 
Present Position: Researcher, Assistant Professor, Institute of Biosciences, Life Sciences Center, Vilnius University
Education:
PhD in Biochemistry, Vilnius University (2024)
MSc in Molecular Biology, Vilnius University (2017)
BSc in Molecular Biology, Vilnius University (2015)
Experience (Past Positions): 2021-2023 Junior Researcher, Institute of Biosciences, Life Sciences Center, Vilnius University
2022-2023 Junior Researcher, EMBL, Life Sciences Center, Vilnius University
2021-2023 Junior Researcher, Institute of Biomedical Sciences, Faculty of Medicine, Vilnius University
2020-2021 Specialist, Institute of Biochemistry, Life Sciences Center, Vilnius University
2017-2018 Visiting Scientist, BioQuant, Heidelberg University
2014-2016 Specialist, Institute of Biosciences (formerly Faculty of Natural Sciences), Life Sciences Center, Vilnius University
Subjects Taught: Laboratory practicals for Bachelor’s students of the Molecular Biology program in the Molecular Biology course.
Practical course for Master’s students of the Molecular Biology study program in the Molecular Cell Biology course. Topic of practice: “Analysing fluorescence microscopy images with Fiji“.
Publications: LABT_LMAVB
Academic Cooperation: Vilnius University Hospital Santaros Clinics Medical Genetics Centre
BioQuant, University of Heidelberg, Heidelberg, Germany
Projects and Grants: 1. “The role of STING activation in the chemotherapeutic agents’ resistance in colorectal cancer cells”. Student‘s research project. Research Council of Lithuania, P-SV3-25-95, Vilnius University, Life Sciences Center, Institute of Biosciences, 2025.07-08 (PI).
2. “Establishment of an Endometrial Cancer Model System for Notch Signalling Pathway Research”, The Research Promotion Fund of Vilnius University, MSF-JM-19/2025, Vilnius University, Life Sciences Center, Institute of Biosciences, 2025-2026 (PI).
3. “Delivery of RNPs and off-targets”. EMBL-PI associated project. Vilnius University, Life Sciences Center, EMBL Partnership Institute, 2022-2023 (participant).
4. “Application of an integrated approach for the investigation of genetic causes of rare inherited disorders”, Research Council of Lithuania, S-MIP-21-15, Vilnius University, Faculty of Medicine, Institute of Biomedical Sciences, 2021-2023 (participant)
5. “CRISPR-Cas13 technology application to investigate resistance to chemotherapy agents”, The Research Promotion Fund of Vilnius University, MSF-JM-2/2021, Vilnius University, Life Sciences Center, Institute of Biosciences, 2021-2022 (PI).
6. “Self-assembling Phage Proteins for Targeted Nanomedicine”, Research Council of Lithuania, S-SEN 20-4, Vilnius University, Life Sciences Center, Institute of Biochemistry, 2020-2021 (participant).
7. “A systems biology approach to analyze the functional interaction of protein coding RNAs and non-coding RNAs”, German Federal Ministry of Education and Research (BMBF), Heidelberg University, Heidelberg, Germany, 2017-2018 (participant).
8. “Carcinoma cells resistance to chemotherapy in vitro: autophagy, cytokines and oxidative stress”, Research Council of Lithuania, Vilnius University, Life Sciences Center, Institute of Biosciences, 2014-2016 (participant).
Qualification Improvement, Sertificates: 2025 Training on "Applying Artificial Intelligence in the Study Process"
2025 Training on "Creating an Engaging Virtual Learning Environment"
2025 EP PerMed Conference on Personalised Medicine Research
2025 Webinar "Tissue engineering and organ-on-chip for different tissue modelling is almost here"
2021 Workshop of "High Throughput Screening and Image Analysis for BioSciences", University of Porto, Portugal
2017 Certificate of FELASA category C
Research Dissemination: VU researchers aim to find out the causes of resistance to chemotherapy drugs, 2022 
Languages: Lithuanian (native), English

 

 
Cookies make it easier for us to provide you with our services. With the usage of our services you permit us to use cookies. More information